WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr | ₹-680 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹334 Cr |
Mar2023 | ₹-315 Cr |
Mar2022 | ₹-71 Cr |
Mar2021 | ₹-1,171 Cr |
Mar2020 | ₹-680 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹334 Cr | Positive | |
Mar2023 | ₹-315 Cr | Negative | |
Mar2022 | ₹-71 Cr | Negative | |
Mar2021 | ₹-1,171 Cr | Negative | |
Mar2020 | ₹-680 Cr | - |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹17,193.1 Cr | 9.8% | 12.9% | 378.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹456,509.0 Cr | 0.9% | 0.2% | 66% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,240.0 Cr | -0.2% | 8% | 66.6% | Stock Analytics | |
CIPLA | ₹121,422.0 Cr | -0.5% | -7.3% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,505.0 Cr | -1.5% | -2.7% | 18.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,293.0 Cr | 1.9% | -5.8% | 72.4% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 9.8% |
12.9% |
378.6% |
SENSEX | -1.4% |
-6.1% |
23.9% |
You may also like the below Video Courses